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Indiscriminate use of antibiotics in apicultural practices may lead to contamination of otherwise healthy and 
naturally produced honey. Contamination not only aff ects honey quality but also pose signifi cant health risks to 
consumers. In this context, one hundred raw honey samples from India were analysed for presence of antibiotic 
residues. For determination of oxytetracycline and erythromycin, high performance liquid chromatography and for 
chloramphenicol, enzyme immunoassay based validated procedures were used. Oxytetracycline and erythromycin 
with concentrations above maximum tolerance limits were detected in 24% and 2% samples, respectively. None of 
the samples contained chloramphenicol residues. Although, total dietary intake of detected antibiotics through honey 
was found to be <1% of their acceptable daily intake values, the presence of antibiotics in honey is an alarming 
health concern for people following customary honey feeding. The outcomes underline the need of inter-sectoral 
approaches to create awareness among beekeepers regarding health risks associated with residues of antibiotics in 
honey and merits of approved apicultural practices. Therefore, to meet global food safety requirements, continual 
residue monitoring schemes along with enlightenment of beekeepers on scientifi c beehive management and risks 
associated with incautious apicultural practices are of vital importance.
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Honey is produced by honey bees that collect nectar from various fl oral sources. India is one 
of the leading producers and exporters of honey in the world. Owing to their diverse botanical 
sources, Northern Indian states such as Himachal Pradesh, Punjab, Haryana, Rajasthan, 
Uttarakhand, and Uttar Pradesh are front runners in honey production (K  et al., 2018). 
Global honey market is also anticipated to register about 2.4 million tons of honey production 
by 2022, and a good deal of this growth can be attributed to common image of honey as a 
simple and natural product devoid of contaminants. Although, beehive products are considered 
healthy and energetic, due to unapproved beekeeping practices and rising environmental 
pollution, they are now being found to be contaminated with various xenobiotics such as 
antibiotics, pesticides, and acaricides. The non-judicious use of antibiotics against bacterial 
foulbrood diseases of honey bees often lead to contamination of honey. The contaminated 
honey may cause harmful human health eff ects, such as yellowing of teeth, gastrointestinal 
disturbances, aplastic anaemia, allergic reactions, and may contribute towards emergence of 
antibiotic resistant bacteria (V  et al., 2014).
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Animal origin foods (milk, meat, eggs, and fi sh) have drawn attention, but safety and 
quality issues pertaining to honey have been largely neglected by veterinary scientists. As per 
OIE, bee colony is regarded as animal and apiary as single epidemiological unit. Therefore, 
research by animal scientists for quality control of honey is vital for welfare of bee farmers 
as well as for food safety and quality assurance. There are international reports of antibiotics 
detected in honey, but such reports from India, especially in raw honey, is meagre (S  
et al., 2006; M  et al., 2014). Hence, present study was envisaged with the objective 
to determine residues of most commonly used antibiotics in raw honeys and assessment of 
human health risks.
1. Materials and methods
1.1. Chemicals and reagents
All chemicals (HPLC or analytical grade) were procured from Merck Life Sciences, India 
(EMPARTA®). Deionised water was purifi ed by Milli-Q system of Millipore, Merck KGaA, 
Germany. Oxytetracycline and erythromycin standards were procured from Sigma Aldrich 
(Fluka Analytical), Germany. Solid phase extraction cartridges were purchased from Waters 
Ltd., USA. Standard stock solutions of antibiotics were prepared by diluting appropriate 
amount of reference standard in organic solvents (methanol for oxytetracycline and 
acetonitrile for erythromycin) to achieve a fi nal concentration of 1 mg ml-1. Stock solutions 
were stored at 4 °C for about 4 weeks. Working standards solutions of oxytetracycline (2.5–
100 ng g–1) and erythromycin (25–1000 ng g–1) were prepared fresh by appropriate dilution 
of standard stock solutions with their respective mobile phases.
1.2. Sample collection
One hundred unprocessed and fresh honey samples were collected randomly from various 
apiaries located in Northern Indian states during honey harvesting seasons. The information 
regarding botanical origins of samples was obtained from beekeepers. Floral origin was 
ascertained in relation to nearby locations and vegetation, where the beehives were installed. 
Honey samples weighing approximately 150 g were stored in amber coloured glass jars for a 
maximum of 4 weeks at –20 °C to prevent any degradation and matrix alterations. Before 
laboratory analyses, samples were liquefi ed at room temperature. For quality control studies, 
one blank (reference) raw honey sample was also collected from a beehive placed in a rural 
area located in the Shivalik ranges of outer Himalayan region in India. The reference blank 
was confi rmed for absence of any antibiotic contamination using validated methods for 
targeted antibiotics.
1.3. Instrumentation
For identifi cation and quantifi cation of oxytetracycline and erythromycin, Agilent 1260 
infi nity HPLC coupled with photo-diode array detector (DAD) supported by OpenLAB 
EZChrom software was used. For chloramphenicol estimation, MaxSignal® Chloramphenicol 
Enzyme Linked Immunosorbent Assay (CAP-ELISA) Test Kits (Product No. 1013-02F) 
purchased from BIOO Scientifi c™ Corp., USA were used. Absorbance of ELISA results was 
measured at 450 nm using Thermo Scientifi c™ Multiskan™ GO microplate spectrophotometer.
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1.4. Sample extraction and analyses
The protocols of P  and co-workers (2002) (for oxytetracycline), W  (2004) (for 
erythromycin) and commercially available kit (for chloramphenicol) with slight modifi cations 
were followed for antibiotics determination in honeys.
For oxytetracycline, honey (5 g) was mixed with 20 ml of 0.1M Na2EDTA-McIlvaine 
buff er (pH 4.0). The sample solution was vortexed for 3 min, followed by sonication for 10 
min. Subsequently, mixture was centrifuged at 4000 × g for 5 min at 25 °C. The supernatant 
was collected and fi ltered through Whatman fi lter paper No.1, and then fi nally passed through 
Oasis™ HLB 3cc (60 mg) cartridge pre-conditioned with 1 ml methanol and 1 ml water. The 
cartridge was then washed with 10 ml water and vacuum dried for 2 min. Finally, sample was 
eluted with 1.5 ml ethyl acetate. After evaporating the solvent at 40 °C in a vacuum 
concentrator, the extracted residues were re-dissolved in 1 ml mobile phase, fi ltered through 
0.22 μm syringe fi lter, and 50 μl was injected to the HPLC system. HPLC analysis was 
carried out using a Zorbax Eclipse XDB C-8, (150 × 4.6 mm i.d., 3 μm particle size) column 
(Agilent) maintained at 25 °C in isocratic conditions with mobile phase of aqueous oxalic 
acid (10 mM), acetonitrile and methanol (70:15:15, v/v) at a fl ow rate of 0.5 ml min–1. Total 
run time was 10 min including 1 min of equilibration time. The detector monitored the analyte 
at 360 nm.
For erythromycin residues, honey (2.5 g) was mixed with 20 ml of 0.1 M phosphate 
buff er (pH 8.0). The solution was vortexed thoroughly and centrifuged at 4000 × g for 5 min 
at 25 °C. Upper layer was then carefully collected and fi ltered using a fl uted Whatman™ 
fi lter paper No.1. The fi ltered sample solution was then passed through Oasis™ HLB 6cc 
(200 mg) SPE cartridge pre-conditioned with methanol (10 ml), water (10 ml), and NaCl 
solution (10 ml, 2%) followed by equilibration using 2 ml of 0.1 M phosphate buff er (pH 
8.0). The cartridge was then rinsed with 5 ml water, 5 ml of 40% methanol in water followed 
by vacuum drying for 5 min. Finally, antibiotics were eluted using 5 ml methanol under 
gravity. After evaporating the eluent at 40 °C in a vacuum concentrator, residues were re-
dissolved in 1 ml of mobile phase, fi ltered through 0.22 μm syringe fi lter, and 100 μl was 
injected to the HPLC system. For chromatographic separation, Zorbax Eclipse ODS C18 
(250 × 4.6 mm i.d., 5 μm particle size) column (Agilent) at 40 °C was used. The mobile phase 
consisting of 20 mM K2HPO4 and acetonitrile (40:60, v/v) was allowed to fl ow at the rate of 
1.4 ml min–1 with total run time of 10 min including 1 min of equilibration time. Detector 
monitored the eluent at 205 nm.
For chloramphenicol residues, a microtiter plate-based, competitive colorimetric 
enzyme immunoassay was used. The sample preparation and testing protocol was employed 
strictly according to the manufacturer’s instructions.
1.5. Analytical performances and method validation
For chromatographic analysis, method validation was carried out following the European 
Commission Decision 657/2002/EC (EC, 2002). Blank honey samples were spiked with 
oxytetracycline and erythromycin at three fortifi cation levels and performance parameters 
were evaluated using matrix matched calibrations.
Linearity was assessed through six-point calibration curves with three replicates. Limit 
of detection (LOD) and limit of quantifi cation (LOQ) were calculated from the calibration 
curve in accordance with International Conference on Harmonisation guidelines (ICH, 2005). 
Trueness (expressed as recovery %) and precision (expressed as % relative standard deviation) 
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were measured by carrying out recovery experiments at three fortifi cation levels. Ruggedness 
of the assay was demonstrated by following small amendments in the protocols. Selectivity 
of protocol was evaluated by injecting extracted blank honey samples and mobile phases. 
The lack of peaks at retention times of targeted antibiotics proved the exclusion of potential 
interfering compounds.
The performance criteria of CAP-ELISA kit were also verifi ed by evaluating the 
linearity, detection limits, trueness, and precisions.
1.6. Human health risk assessment
For assessment of potential human health risks associated with oral intake of antibiotic 
residues through honey, estimated daily intakes (EDIs) were compared with the already 
established ADIs for all detected antibiotics to calculate Hazard Index (HI=EDI/ADI). EDI 
of residues was calculated for each antibiotic using the following equation:
 C × F
EDI= _______
 D × W
wherein, C is mean antibiotic residue concentration in honey (μg kg–1), F is mean annual 
intake of honey per person in India, D is number of days in a year, and W is mean human 
body weight (60 kg for adults and 15 kg for children).
2. Results and discussion
2.1. Method validation parameters
The method performance parameters for antibiotics determination were found to be 
satisfactory (Table 1). Matrix matched calibration curves exhibited good linearity with 
coeffi  cient of determination >0.99. The obtained LOD and LOQ values showed high method 
sensitivity for antibiotics. The methods showed high selectivity, without any interference 
close to the retention time of each compound. Mean recoveries (85.2% to 90.4%) were within 
the acceptable range, and the relative standard deviation% was also found to be <20%.
The CAP-ELISA was also found to be linear in the range of 0.05–4.5 ng g–1. The mean 
recoveries obtained by spiking blank honey samples at three fortifi cation levels were ranging 
between 77.3 to 83.1% (Table 1).
2.2. Antibiotics in raw honey samples
HPLC-DAD analyses of 100 raw honey samples comprising of 83 unifl oral (originating from 
mustard, eucalyptus, Egyptian clover, litchi, coriander, cotton, jujube, rosewood tree, and 
sunfl ower) and 17 multifl oral honeys revealed oxytetracycline residues in 25 samples with 
mean concentration of 69.3±5.7 ng g–1 (Table 2). Twenty-four samples contained 
oxytetracycline residues above the tolerance limit of 5 ng g–1 established by Food Safety and 
Standards Authority of India (FSSAI, 2014). Oxytetracycline concentrations ranging between 
4.8 and 204 ng g–1 suggest that even though antibiotic usage in apiculture is not recommended 
by the National Bee Board of India, if not all, some beekeepers still continue the unadvised 
practice. This is further supported by the knowledge, attitude, and practices based study 
conducted during sampling, wherein 70% of small beekeepers believed in antibiotic usage 
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for protection of beehives from diseases, and they were even unaware of the fact that 
antibiotics residues can appear in honey (K  et al., 2019). These results are in agreement 
with those reported for Indian honey by other authors (J  et al., 2010; R  et al., 
2015).
Table 1. Quality control parameters for antibiotics detection in honey
Parameters Oxytetracycline Erythromycin Chloramphenicol
Analytical technique HPCD-DAD HPLC-DAD Competitive ELISA
Regression equation y=15004x–18600 y=55381x–143883 y= –18.101x+40.995
R2 0.9998 0.9998 0.9842
LOD (ng g–1) 1.62 1.58 0.05
LOQ (ng g–1) 4.86 4.74 0.15
Recovery Studies (n=3)
Recovery ± RSD% at fortifi cation 
Level 1 97.0±4.6 89.2±4.6 77.3±1.3
Recovery ± RSD% at fortifi cation 
Level 2 83.9±2.3 83.4±2.1 83.1±0.7
Recovery ± RSD% at fortifi cation 
Level 3 90.4±0.3 82.9±1.7 78.6±0.9
Overall recovery% (Trueness) 90.4 85.2 79.7
RSD  % (Precision) 3.0 3.1 1.0
Table 2. Antibiotic residues detected in raw honey samples (N = 100)








Oxytetracycline 25 69.3±5.7 4.8 204 24
Erythromycin 2 53.0±2.8 51.0 55.0 2
Chloramphenicol Not detected – – – –
n= number of positive samples; a mean ± standard deviation of positive samples
Of all honey samples, only two samples contained erythromycin with mean concentration 
of 53.0±2.8 ng g–1. For comparison of obtained results, very few reports are available in 
published literature regarding presence of erythromycin residues in honey. J  and co-
workers (2010) reported that 42% of market honey samples in India contained erythromycin 
residues with concentrations ranging from 69.7 to 280.3 ng g–1. In turkey, G  and co-
workers (2008) found erythromycin in 8% of the honey samples with maximum content as 
high as 1776 ng g–1. However, present study revealing overall frequency of erythromycin in 
only 2% of the samples with maximum quantifi ed concentration of 55 ng g–1 is relatively very 
low in comparison to some of the earlier studies. This could probably be attributed to non-
availability of erythromycin and frequent use of its cheaper analogues such as azithromycin 
or clarithromycin in India (B   S , 2006), but such hypothesis needs to be 
tested in future studies.
Although, the use of chloramphenicol in food producing animals has been banned in 
many countries, there were reports of its detection in honey marketed in India (L , 
2007). Subsequently, FSSAI (2014) established tolerance limit (0.3 ng g–1) for chloramphenicol 
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residues in honey. Therefore, CAP-ELISA with detection limits of 0.05 ng g–1 was employed 
for its detection. None of the samples contained chloramphenicol residues. Hence, 
oxytetracycline was found to be the major antibiotic followed by erythromycin as contaminant 
in raw honey samples.
Antibiotics are also employed in orchards for treatment of various plant diseases. 
Therefore, their residues can obviously be found in honey bee products due to contaminated 
collected pollens. However, critical perusal of results revealed statistically non-signifi cant 
correlation between antibiotic residues and fl oral origin of honey. Therefore, it might be safe 
to hypothesise that the antibiotic residues in honey originated largely from incautious 
apicultural practices and certainly not from horticultural/environmental sources.
Oxytetracycline is the most frequently used antibiotic to treat bacterial foulbrood 
diseases of honey bees. However, there are reports of tetracycline resistance in these bacteria. 
Therefore, recently, alternate antibiotics such as erythromycin and chloramphenicol have 
been administered to bee colonies by beekeepers (M   P , 2015). This could be 
the reason for the use of antibiotics in apiculture settings despite various restrictions and 
limits imposed by the government on their use. Due to stringent regulations on food safety, 
there has been a substantial decrease in occurrence of antibiotics in honey, especially from 
Indian, American, and European markets (R , 2018; USFDA, 2019), but even the 
trace presence of such contaminant is alarming and potentially dangerous for consumers’ 
health, and therefore, needs utmost attention.
2.3. Human health risk assessment
The HI value was <1 i.e. intake of antibiotic residues through honey remains clearly below 
the safe limits (Table 3). The human health risk assessment signifi es that there are no acute 
eff ects and there is negligible risk to consumers’ health at current levels of honey contamination 
and consumption pattern. But continuous, sub-therapeutic, and long term exposures of these 
antibiotics can pose signifi cant risk to human health. Therefore, health education of 
beekeepers, routine monitoring of antibiotic residues in honey, and precautionary measures, 
especially while feeding infants, old and ill people, should always be carefully considered to 
safeguard human health.




Age Group Honey samples
EDI HI % ADI
Oxytetracycline 3.0 Adult 2.22E-04 7.38E-05 7.38E-03
Children 1.33E-03 4.43E-04 4.43E-02
Erythromycin 0.7 Adult 1.69E-04 2.42E-04 2.42E-02
Children 1.02E-03 1.45E-03 1.45E-01
3. Conclusions
In conclusion, honey samples were found to contain oxytetracycline residues relatively in 
higher proportions as compared to other targeted antibiotics. The occurrence of antibiotic 
residues in honey suggests poor management practices followed by the distressed beekeepers 
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for avoiding economic losses and saving their beehives from infectious diseases. Therefore, 
to avoid any injudicious use or misuse of antibiotics in apicultural practices, there is an urgent 
need to increase the awareness levels of beekeepers on beehive management and 
simultaneously of consumers on food safety and human health issues. Furthermore, eff ective 
enforcement of food safety regulations and nationwide continuous residue monitoring 
programs are of utmost essentiality to preclude contamination of honey.
*
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Angad Dev Veterinary and Animal Sciences University, Ludhiana, Punjab for providing necessary facilities to carry 
out the present research.
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